I will share my Mayo letter about monoclonal antibodies.

Dear Mayo Clinic Transplant Patient,

As COVID-19 continues to circulate around our communities, we want to send a reminder to continue to practice social distancing, avoid crowded spaces, and to wear masks or face coverings.

With a recent Food and Drug Administration Emergency Use Authorization, we would like to inform you of a new treatment that may be available to you in case of an exposure to a known COVID-19 positive individual. This monoclonal antibody known as REGEN-COV is to be administered as soon as possible after an exposure to COVID-19 individual. If you have an exposure to someone with COVID-19, please notify your transplant team as soon as possible, so that they can refer you to the COVID-19 treatment team to review if you qualify for this post-exposure prophylaxis.

We continue to recommend completing the COVID-19 vaccination for all of our transplant patients and will be contacting patients pro-actively in a separate communication regarding scheduling the recently approved 3rd dose mRNA COVID-19 vaccine to those who are eligible. For immediately transplanted patients, due to the amount of medication used to lower the immune system at the time of your transplant which affects your body’s response to the vaccine, it is advised that those who received a bone marrow transplant, kidney transplant, heart transplant, heart & lung transplant, or a pancreas transplant should wait until 3 months after your transplant to receive your third COVID vaccination. Patients who are immediately post liver and lung transplant are advised to wait until at least 1-month post-transplant.

Thank you for trusting your health care to Mayo Clinic.

Sincerely,

Your Mayo Clinic Healthcare Team